You haven't searched anything yet.
Porton Pharma Solutions Ltd. is a leading global provider of comprehensive process R&D and manufacturing services to the pharmaceutical industry. We specialize in offering end-to-end solutions for small molecule APIs, dosage forms, and biologics. With a focus on innovation and customer satisfaction, we are committed to delivering high-quality products and services that meet the industry's evolving needs. Our experienced team of experts works tirelessly to ensure every project is completed on time, within budget, and to the highest possible standards. Whether you need support with drug development, manufacturing, or regulatory compliance, Porton Pharma Solutions Ltd. has the expertise and capabilities to help you achieve your goals.
J-STAR Research, Inc. is a subsidiary of Porton that specializes in providing contract chemistry services to the biopharmaceutical and biotechnology industry. Our primary focus is resolving intricate chemistry problems relating to Active Pharmaceutical Ingredients and Intermediates in the preclinical and clinical development phases. We are adept in synthetic chemistry and process research services, which include Process Chemistry, Quality Control, Good Manufacturing Practice, Quality Assurance, Crystallization Research and Development, Solid Form and Polymorph Screening, Catalysis Screening and Enabling Technology, High Potent Compound Handling (HPAPI), Impurity Isolation and Structural Elucidation, and Preformulation and Formulation Research and Development.
At J-Star, there are 5 NMR systems including one 500 MHz H/C/N Cryoprobe as well as two 400 MHz Bruker systems with multiple-nuclear and variable temperature capabilities. We are hiring an NMR Spectroscopist to support project team decisions and improve the speedy delivery of API for our clients.
Location: Cranbury and South Plainfield, NJ
Responsibilities:
Requirement Qualifications:
Job Type: Full-time
Benefits:
Schedule:
Experience:
Ability to Relocate:
Work Location: In person
Full Time
$103k-129k (estimate)
04/10/2024
05/10/2024